Yahoo
NasdaqGS - Delayed Quote USD

Amneal Pharmaceuticals, Inc. (AMRX)

17.44 -0.43 (-2.41%)
At close: September 4 at 4:00:01 PM EDT
17.44 0.00 (0.00%)
After hours: September 4 at 7:30:04 PM EDT
Trade AMRX on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
3,117,548
3,018,760
2,793,957
2,393,607
2,212,304
Cost of Revenue
1,891,763
1,905,452
1,773,519
1,573,042
1,427,596
Gross Profit
1,225,785
1,113,308
1,020,438
820,565
784,708
Operating Expense
746,546
715,394
672,065
581,818
595,786
Operating Income
479,239
397,914
348,373
238,747
188,922
Net Non Operating Interest Income Expense
-262,330
-272,456
-258,595
-251,434
-158,668
Other Income Expense
-15,731
13,751
-144,791
-27,583
-278,381
Pretax Income
201,178
139,209
-55,013
-40,270
-248,127
Tax Provision
-14,141
11,276
18,863
8,452
6,662
Net Income Common Stockholders
157,363
72,057
-116,886
-83,993
-129,986
Diluted NI Available to Com Stockholders
157,363
72,057
-116,886
-83,993
-129,986
Basic EPS
0.50
0.23
-0.38
-0.48
-0.86
Diluted EPS
0.48
0.22
-0.38
-0.48
-0.86
Basic Average Shares
315,975
313,367
308,978
176,136
150,944
Diluted Average Shares
327,483
324,805
308,978
176,136
150,944
Total Operating Income as Reported
453,918
394,096
249,326
204,374
-94,928
Total Expenses
2,638,309
2,620,846
2,445,584
2,154,860
2,023,382
Net Income from Continuing & Discontinued Operation
157,363
72,057
-116,886
-83,993
-129,986
Normalized Income
176,278.60
74,603.55
6,806.67
-55,690.46
104,521.55
Interest Expense
227,455
241,091
258,595
210,629
158,377
Net Interest Income
-262,330
-272,456
-258,595
-251,434
-158,668
EBIT
428,633
380,300
203,582
170,359
-89,750
EBITDA
622,924
603,872
439,773
399,759
150,425
Reconciled Cost of Revenue
1,891,763
1,905,452
1,773,519
1,573,042
1,427,596
Reconciled Depreciation
194,291
223,572
236,191
229,400
240,175
Net Income from Continuing Operation Net Minority Interest
157,363
72,057
-116,886
-83,993
-129,986
Total Unusual Items Excluding Goodwill
-31,526
-2,771
-156,573
-35,826
-296,845
Total Unusual Items
-31,526
-2,771
-156,573
-35,826
-296,845
Normalized EBITDA
654,450
606,643
596,346
435,585
447,270
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-12,610.40
-224.45
-32,880.33
-7,523.46
-62,337.45
12/31/2022 - 5/7/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: